PROTHENA CORPORATION PUBLIC LIMITED COMPANY Shareholders' Equity
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Shareholders' Equity of $286.89 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $286.89M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $312.62M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $280.47M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $294.99M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $286.89M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $312.62M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $280.47M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $294.99M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $324.33M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $437.68M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $486.93M 10-K · filed 2026-02-27 |
| 2024-09-30 | $534.36M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $581.92M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $502.40M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $561.37M 10-K · filed 2025-02-27 |
| 2023-09-30 | $617.23M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $581.68M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $607.41M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $622.04M 10-K · filed 2024-02-22 |
| 2022-09-30 | $404.65M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $407.30M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $438.89M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $466.04M 10-K · filed 2023-02-28 |
| 2021-09-30 | $490.47M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $288.21M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $234.58M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $184.01M 10-K · filed 2022-02-25 |
| 2020-09-30 | $209.51M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $234.44M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $255.04M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $272.92M 10-K · filed 2021-02-26 |
| 2019-09-30 | $289.18M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $302.81M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $312.13M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $323.00M 10-K · filed 2020-03-03 |
| 2018-09-30 | $339.65M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $356.01M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $409.50M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $407.19M 10-K · filed 2019-03-15 |
| 2017-09-30 | $446.25M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $486.98M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $496.25M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $365.40M 10-K · filed 2018-02-26 |
| 2016-09-30 | $401.10M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $430.87M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $465.78M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $360.67M 10-K · filed 2017-02-27 |
| 2015-09-30 | $377.95M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $395.22M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $277.43M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $289.89M 10-K · filed 2016-02-25 |
| 2014-09-30 | $301.56M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $298.42M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $193.01M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $173.27M 10-K · filed 2015-03-13 |
| 2013-09-30 | $98.78M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $107.23M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $117.79M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $126.48M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |